Cardiovascular Diseases, Embolism and Thrombosis, Ovarian Hyperstimulation Syndrome
Conditions
Brief summary
This study aims at evaluating clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation. Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous thrombosis in women undergoing assisted reproductive technology and 2)to identify the incidence and risk factors for ovarian hyperstimulation syndrome in these women
Detailed description
All women undergoing an assisted reproductive tecnology in order to receive an in vitro fertilization in French centers will be included in the study. These women will be followed up until 12 months after ovarian stimulation if they get pregnant or until 3 months if the stimulation does not lead to pregnancy. Risk factors for thrombosis and ovarian hyperstimulation syndrome will be collected in each woman. At each visit, women will be asked whether arterial and/or venous thrombosis had occured.
Interventions
OTHERovarian stimulation
evaluation of clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation
Sponsors
University Hospital, Brest
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All women undergoing ovarian stimulation in order to receive in vitro fertilization
Exclusion criteria
* Age\<18 years * Women refusing to particpate in the study * No health coverage * Women under guardianship * Women receiving therapeutic doses of anticoagulation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of professional clinical practice for ovarian stimulation care | Until 12 months followin ovarian stimulation |
Secondary
| Measure | Time frame |
|---|---|
| Arterial and/or venous thrombosis | until 12 months following ovarian stimulation |
| Risk factors for thrombosis | until 12 months following ovarian stimulation |
Other
| Measure | Time frame |
|---|---|
| Incidence and risk factors for ovarian hyperstimuation syndrome | until 12 months following ovarian stimulation |
Countries
France
Outcome results
None listed